Alerts will be sent to your verified email
Verify EmailCCLINTER
CCL International
|
Binny Mills
|
Novelix Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
2.82 % | 2.38 % | -17.5 % |
5yr average Equity Multiplier
|
1.58 | -1.02 | 1.26 |
5yr Average Asset Turnover Ratio
|
0.55 | 0.04 | 0.84 |
5yr Avg Net Profit Margin
|
1.6 % | -67.35 % | -14.11 % |
Price to Book
|
1.27 | 0.0 | 8.06 |
P/E
|
52.72 | 0.0 | 102.3 |
5yr Avg Cash Conversion Cycle
|
190.64 Days | 15.76 Days | 29.1 Days |
Inventory Days
|
121.28 Days | 84.09 Days | 34.04 Days |
Days Receivable
|
124.06 Days | 20.05 Days | 55.38 Days |
Days Payable
|
98.58 Days | 129.33 Days | 55.7 Days |
5yr Average Interest Coverage Ratio
|
1.31 | 0.6 | -17.77 |
5yr Avg ROCE
|
5.11 % | -152.87 % | -15.4 % |
5yr Avg Operating Profit Margin
|
7.39 % | 5.31 % | -16.49 % |
5 yr average Debt to Equity
|
0.4 | -0.82 | 0.05 |
5yr CAGR Net Profit
|
-13.7 % | n/a | 35.78 % |
5yr Average Return on Assets
|
1.63 % | -3.02 % | -13.36 % |
Shareholdings
|
|||
Promoter Holding
|
63.86 % | 68.97 % | 52.75 % |
Share Pledged by Promoters
|
1.63 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
7.31 % | -5.89 % | -14.17 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
CCL International
|
Binny Mills
|
Novelix Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|